GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 599.3B
Enterprise value 3100.81B
Trailing P/E 40.32
Forward P/E 10.17
PEG ratio (5-yr expected) 13.02
Price/sales (ttm)N/A
Price/book (mrq)16.63
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3-0.49%
S&P500 52-week change 35.66%
52-week high 324.20
52-week low 314.96
50-day moving average 320.49
200-day moving average 320.75

Share statistics

Avg vol (3-month) 35.81k
Avg vol (10-day) 31.46k
Shares outstanding 55.02B
Float 4.92B
% held by insiders 10.93%
% held by institutions 149.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.93
Forward annual dividend yield 44.58%
Trailing annual dividend rate 31.06
Trailing annual dividend yield 35.22%
5-year average dividend yield 45.30
Payout ratio 474.70%
Dividend date 308 Apr 2015
Ex-dividend date 413 May 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020


Profit margin 15.29%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)7.78%
Return on equity (ttm)50.81%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)18.70%
Gross profit (ttm)22.97B
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.50
Quarterly earnings growth (yoy)88.60%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)159.26
Current ratio (mrq)0.87
Book value per share (mrq)1.20

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more